SCHEMBL432732

SCHEMBL432732

CCCCN(CCCC)CCCc1ccc(C(C)=O)cc1

nearest known ligand 0.64

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
THRA P10827 3/20 0.64
THRB P10828 3/20 0.64
HSD17B10 Q99714 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL967078 0.86 HSD17B10 (0.67) THRATHRBHSD17B10
SCHEMBL963847 0.84 THRA (0.67) THRATHRBHSD17B10
SCHEMBL9997622 0.82 THRA (0.70) THRATHRBHSD17B10
SCHEMBL965453 0.82 THRA (0.70) THRATHRBHSD17B10
SCHEMBL28733046 0.82 THRA (0.70) THRATHRBHSD17B10
SCHEMBL4185050 0.82 THRA (0.70) THRATHRBHSD17B10
SCHEMBL499485 0.82 THRA (0.70) THRATHRBHSD17B10
SCHEMBL965858 0.82 THRA (0.70) THRATHRBHSD17B10
SCHEMBL8383207 0.82 THRA (0.70) THRATHRBHSD17B10
SCHEMBL12457863 0.82 THRA (0.70) THRATHRBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8748636-B2 Process for preparing benzofuran derivatives substituted at position 5 SANOFI (FR) 2014-06-10 US disclosed
US-8748636-B2 Process for preparing benzofuran derivatives substituted at position 5 SANOFI (FR) 2014-06-10 US disclosed
US-8748636-B2 Process for preparing benzofuran derivatives substituted at position 5 SANOFI (FR) 2014-06-10 US disclosed
US-20130165674-A1 PROCESS FOR PREPARING BENZOFURAN DERIVATIVES SUBSTITUTED AT POSITION 5 SANOFI (FR) 2013-06-27 US disclosed
US-20130165674-A1 PROCESS FOR PREPARING BENZOFURAN DERIVATIVES SUBSTITUTED AT POSITION 5 SANOFI (FR) 2013-06-27 US disclosed
US-20130165674-A1 PROCESS FOR PREPARING BENZOFURAN DERIVATIVES SUBSTITUTED AT POSITION 5 SANOFI (FR) 2013-06-27 US disclosed
EP-2595977-A1 PROCESS FOR PREPARING BENZOFURAN DERIVATIVES SUBSTITUTED AT POSITION 5 SANOFI (FR) 2013-05-29 EP disclosed
WO-2012010802-A1 PROCESS FOR PREPARING BENZOFURAN DERIVATIVES SUBSTITUTED AT POSITION 5 SANOFI (FR) 2012-01-26 WO disclosed
WO-2012010802-A1 PROCESS FOR PREPARING BENZOFURAN DERIVATIVES SUBSTITUTED AT POSITION 5 SANOFI (FR) 2012-01-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165674-A1 PROCESS FOR PREPARING BENZOFURAN DERIVATIVES SUBSTITUTED AT POSITION 5 DHPS, SDHA, CYP2F1 THRA 3592/4885THRB 3390/4885HSD17B10 129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.